| Pharmaceutical Information |
| Drug Name |
Viloxazine |
| Drug ID |
BADD_D02607 |
| Description |
Viloxazine is a selective norepinephrine reuptake inhibitor (NRI) that was used in some European countries as an antidepressant drug. It structurally differs from conventional tri- or tetra-cyclic antidepressants and it does not produce sedative anticholinergic or adrenergic effects in man [A19781]. While displaying amphetamine-like CNS stimulant effects, there is little evidence of drug dependence from viloxazine therapy. Viloxazine hydrochloride is a common active ingredient in drug formulation. It was discovered and brought to market in 1976 by Imperial Chemical Industries and in early 2000's, it was withdrawn from the market. |
| Indications and Usage |
Indicated for the treatment of clinical depression. |
| Marketing Status |
approved; investigational; withdrawn |
| ATC Code |
N06AX09 |
| DrugBank ID |
DB09185
|
| KEGG ID |
D08673
|
| MeSH ID |
D014745
|
| PubChem ID |
5666
|
| TTD Drug ID |
D0V9JR
|
| NDC Product Code |
70600-039 |
| UNII |
5I5Y2789ZF
|
| Synonyms |
Viloxazine | ICI-58,834 | ICI58,834 | Viloxazine Hydrochloride | Viloxazine Hydrochloride, (R)-Isomer | Vivalan | Viloxazine Oxalate (1:1) | Viloxazine, (+-)-Isomer | Viloxazine, (R)-Isomer | Viloxazine, (S)-Isomer | Emovit | Viloxazine Hydrochloride, (S)-Isomer |
|
| Chemical Information |
| Molecular Formula |
C13H19NO3 |
| CAS Registry Number |
46817-91-8 |
| SMILES |
CCOC1=CC=CC=C1OCC2CNCCO2 |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
